Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling

Yale J Biol Med. Sep-Dec 1997;70(5-6):541-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • CHO Cells / drug effects
  • CHO Cells / metabolism
  • Cell Cycle / drug effects
  • Cell Cycle / genetics
  • Cell Division / drug effects
  • Cell Division / physiology*
  • Cricetinae
  • Endonucleases / metabolism
  • G1 Phase / drug effects
  • G1 Phase / genetics
  • Humans
  • Octreotide
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2*
  • Receptors, Somatostatin / drug effects
  • Receptors, Somatostatin / physiology*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Signal Transduction*
  • Tumor Suppressor Protein p53 / drug effects
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • bcl-2-Associated X Protein

Substances

  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Somatostatin
  • Recombinant Proteins
  • Tumor Suppressor Protein p53
  • bcl-2-Associated X Protein
  • Endonucleases
  • Octreotide